$NBIX

$160.00▲ +9.5% YTD

10 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

NBIX ▲ +9.5% - Neurocrine Biosciences, Inc.

CP $160.00▲ +9.5%Nov 2, 2026 · ThinkSabio Blog

$NBIX NBIX - Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results…

News

NBIX ▼ -1.2% - Neurocrine Biosciences, Inc.

CP $144.32▲ -1.2%Nov 2, 2026 · ThinkSabio Blog

Another Prader Willi patient prescribed Neurocrine's $NBIX Vykat has died, according to the FDA's AEMS database. That's the eighth patient death repor…

SEC 13D/G

NBIX - Neurocrine Biosciences, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks Simplified

$147.45▲ 4.86%Oct 30, 2026 · ThinkSabio Blog

$NBIX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NBIX Neurocrine Biosciences, Inc. : $147.45 Sector: Healthcare…

News

NBIX ▼ -0.3% - Neurocrine Biosciences, Inc.

CP $146.00▲ -0.3%Oct 30, 2026 · ThinkSabio Blog

$NBIX NBIX - Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia…

News

NBIX ▲ +0.1% - Neurocrine Biosciences, Inc.

CP $142.91▲ +0.1%Oct 26, 2026 · ThinkSabio Blog

$NBIX NBIX - Neurocrine Biosciences Presents New Analysis Establishing Benchmark for Clinically Meaningful Change in Overall Health Reported by Patien…

News

NBIX ▲ +1.4% - Neurocrine Biosciences, Inc.

CP $143.29▲ +1.4%Oct 22, 2026 · ThinkSabio Blog

$NBIX NBIX - Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi…

News

NBIX ▲ +0.0% - Neurocrine Biosciences, Inc.

CP $136.95▲ +0.0%Oct 16, 2026 · ThinkSabio Blog

$NBIX - Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia…

SEC 13D/G

NBIX - Neurocrine Biosciences, Inc. - SEC Filing Update (15-OCT-2026) | ThinkSabio - Stocks Simplified

$137.18▼ -2.44%Oct 15, 2026 · ThinkSabio Blog

$NBIX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NBIX Neurocrine Biosciences, Inc. : $137.18 Sector: Healthcare…

News

NBIX ▼ -0.7% - Neurocrine Biosciences, Inc.

CP $141.37▲ -0.7%Oct 12, 2026 · ThinkSabio Blog

$NBIX NBIX - Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results…

SEC 13D/G

$NBIX SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified

$177.52▲ 26.25%Jul 27, 2026 · ThinkSabio Blog

$NBIX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NBIX : $177.52 Sector: Healthcare | YTD: 🔼+ 26.25% The SEC disc…